|
US6608182B1
(en)
|
1994-03-08 |
2003-08-19 |
Human Genome Sciences, Inc. |
Human vascular endothelial growth factor 2
|
|
US6040157A
(en)
|
1994-03-08 |
2000-03-21 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
|
DK0751992T3
(da)
|
1994-03-08 |
2006-03-06 |
Human Genome Sciences Inc |
Karendotelvækstfaktor 2
|
|
US7186688B1
(en)
|
1994-03-08 |
2007-03-06 |
Human Genome Sciences, Inc. |
Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
|
|
US7153827B1
(en)
|
1994-03-08 |
2006-12-26 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 and methods of use
|
|
US7109308B1
(en)
|
1994-03-08 |
2006-09-19 |
Human Genome Sciences, Inc. |
Antibodies to human vascular endothelial growth factor 2
|
|
US5932540A
(en)
|
1994-03-08 |
1999-08-03 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
|
US7223724B1
(en)
|
1999-02-08 |
2007-05-29 |
Human Genome Sciences, Inc. |
Use of vascular endothelial growth factor to treat photoreceptor cells
|
|
SK12942002A3
(sk)
|
2000-02-10 |
2003-05-02 |
Abbott Laboratories |
Protilátky viažuce ľudský interleukín-18, spôsoby ich výroby a použitia
|
|
RS51737B
(sr)
*
|
2000-02-21 |
2011-10-31 |
Laboratoires Serono Sa. |
Korišćenje inhibitora il-18
|
|
US20020025317A1
(en)
*
|
2000-07-20 |
2002-02-28 |
Schering Ag |
Bispecific monoclonal antibodies to IL-12 and IL-18
|
|
KR20020059609A
(ko)
|
2000-08-04 |
2002-07-13 |
벤슨 로버트 에이치. |
혈관 내피 성장 인자 ２
|
|
IL157024A0
(en)
*
|
2001-01-29 |
2004-02-08 |
Applied Research Systems |
Il-18 inhibitors in heart disease
|
|
JP2004536579A
(ja)
*
|
2001-04-13 |
2004-12-09 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
血管内皮増殖因子２
|
|
US7402312B2
(en)
|
2001-04-13 |
2008-07-22 |
Human Genome Sciences, Inc. |
Antibodies to vascular endothelial growth factor 2 (VEGF-2)
|
|
BR0210904A
(pt)
*
|
2001-05-16 |
2005-08-16 |
Yeda Res & Dev |
Uso de inibidores de il-18 para o tratamento ou prevenção de sepse
|
|
US20040213786A1
(en)
*
|
2001-08-24 |
2004-10-28 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for treating T-cell mediated autoimmune diseases
|
|
BRPI0214168B8
(pt)
|
2001-11-14 |
2021-05-25 |
Centocor Inc |
anticorpos anti-il-6, moléculas de ácido nucleico codificando os mesmos, vetores compreendendo as referidas moléculas, composições e formulações compreendendo os referidos anticorpos, bem como métodos de produção dos mesmos
|
|
US20040018195A1
(en)
*
|
2002-03-26 |
2004-01-29 |
Griswold Don Edgar |
Diabetes-related immunoglobulin derived proteins, compositions, methods and uses
|
|
WO2003082922A1
(en)
*
|
2002-03-28 |
2003-10-09 |
Markus Fritzsche |
Antibody against an epitope of the b. burgdorferi flagellar basal rod protein (fbrp)
|
|
US7253260B2
(en)
|
2002-04-17 |
2007-08-07 |
Smithkline Beecham Corporation |
Human IL-18 crystal structure
|
|
US7601351B1
(en)
|
2002-06-26 |
2009-10-13 |
Human Genome Sciences, Inc. |
Antibodies against protective antigen
|
|
WO2004003144A2
(en)
|
2002-07-01 |
2004-01-08 |
Human Genome Sciences, Inc. |
Antibodies that specifically bind to reg iv
|
|
US9415102B2
(en)
|
2002-09-06 |
2016-08-16 |
Alexion Pharmaceuticals, Inc. |
High concentration formulations of anti-C5 antibodies
|
|
US20050271660A1
(en)
|
2002-09-06 |
2005-12-08 |
Alexion Pharmaceuticals, Inc. |
Nebulization of monoclonal antibodies for treating pulmonary diseases
|
|
US7261893B2
(en)
|
2002-10-22 |
2007-08-28 |
Wyeth |
Neutralizing antibodies against GDF-8 and uses therefor
|
|
NZ540194A
(en)
|
2002-11-08 |
2008-07-31 |
Ablynx Nv |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
US20060034845A1
(en)
|
2002-11-08 |
2006-02-16 |
Karen Silence |
Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
|
|
US9320792B2
(en)
|
2002-11-08 |
2016-04-26 |
Ablynx N.V. |
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
|
|
EP1558645B1
(en)
*
|
2002-11-08 |
2011-07-27 |
Ablynx N.V. |
Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation
|
|
WO2004097019A1
(ja)
*
|
2003-04-30 |
2004-11-11 |
Japan Science And Technology Agency |
ヒト抗ヒトインターロイキン－１８抗体およびその断片、並びにそれらの利用方法
|
|
GB0323965D0
(en)
*
|
2003-10-13 |
2003-11-19 |
Glaxosmithkline Biolog Sa |
Immunogenic compositions
|
|
AU2011224023C1
(en)
*
|
2003-11-12 |
2013-08-29 |
Abbvie Inc. |
IL-18 binding proteins
|
|
US20050100965A1
(en)
|
2003-11-12 |
2005-05-12 |
Tariq Ghayur |
IL-18 binding proteins
|
|
US7968684B2
(en)
*
|
2003-11-12 |
2011-06-28 |
Abbott Laboratories |
IL-18 binding proteins
|
|
US20050227289A1
(en)
|
2004-04-09 |
2005-10-13 |
Reilly Edward B |
Antibodies to erythropoietin receptor and uses thereof
|
|
JP5069000B2
(ja)
*
|
2004-06-30 |
2012-11-07 |
敦生 関山 |
非炎症性ストレス応答の指標剤およびその利用
|
|
US7141382B1
(en)
|
2004-10-12 |
2006-11-28 |
Parikh Chirag R |
Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality
|
|
PA8672101A1
(es)
|
2005-04-29 |
2006-12-07 |
Centocor Inc |
Anticuerpos anti-il-6, composiciones, métodos y usos
|
|
KR20140053410A
(ko)
|
2005-08-19 |
2014-05-07 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
EP2500353A3
(en)
|
2005-08-19 |
2012-10-10 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
CN101277974A
(zh)
|
2005-09-30 |
2008-10-01 |
阿伯特有限及两合公司 |
排斥性引导分子(rgm)蛋白质家族的蛋白质的结合结构域及其功能性片段和它们的用途
|
|
SI1964852T1
(sl)
*
|
2005-12-20 |
2013-09-30 |
Sbi Biotech Co. Ltd. |
Proti-ilt7 protitelo
|
|
TWI417301B
(zh)
*
|
2006-02-21 |
2013-12-01 |
Wyeth Corp |
對抗人類介白素-２２（ｉｌ-２２）之抗體及其用途
|
|
MX2008014842A
(es)
|
2006-05-25 |
2009-02-17 |
Glaxo Group Ltd |
Anticuerpos humanizados contra interleuquina-18 modificados.
|
|
TW201516149A
(zh)
|
2006-09-13 |
2015-05-01 |
Abbvie Inc |
細胞培養改良
|
|
US8911964B2
(en)
|
2006-09-13 |
2014-12-16 |
Abbvie Inc. |
Fed-batch method of making human anti-TNF-alpha antibody
|
|
EP2500416A1
(en)
|
2006-09-13 |
2012-09-19 |
Abbott Laboratories |
Cell culture improvements
|
|
US8883960B2
(en)
|
2007-01-04 |
2014-11-11 |
Sk Chemicals Co., Ltd. |
Polyarylene sulfide resin with excellent luminosity and preparation method thereof
|
|
WO2008150431A1
(en)
*
|
2007-05-29 |
2008-12-11 |
Yale University |
Il- 18 and protein kinase r inhibition for the treatment of copd
|
|
CL2008002153A1
(es)
|
2007-07-24 |
2009-06-05 |
Amgen Inc |
Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
|
|
EP2238167B1
(en)
|
2007-12-27 |
2015-04-22 |
Abbott Laboratories |
Anti-t. cruzi antibodies and methods of use
|
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
|
EP2282769A4
(en)
|
2008-04-29 |
2012-04-25 |
Abbott Lab |
DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND ITS USES
|
|
EP2297209A4
(en)
|
2008-06-03 |
2012-08-01 |
Abbott Lab |
IMMUNOGLOBULINS WITH TWO VARIABLE DOMAINS AND USES THEREOF
|
|
KR20110016959A
(ko)
|
2008-06-03 |
2011-02-18 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
|
US8188235B2
(en)
|
2008-06-18 |
2012-05-29 |
Pfizer Inc. |
Antibodies to IL-6 and their uses
|
|
US8822645B2
(en)
|
2008-07-08 |
2014-09-02 |
Abbvie Inc. |
Prostaglandin E2 dual variable domain immunoglobulins and uses thereof
|
|
CN102257004A
(zh)
*
|
2008-10-20 |
2011-11-23 |
雅培制药有限公司 |
与il-12结合的抗体及其纯化方法
|
|
CN104974251A
(zh)
|
2008-10-20 |
2015-10-14 |
Abbvie公司 |
在抗体纯化过程中的病毒灭活
|
|
CA2932207A1
(en)
*
|
2008-10-20 |
2010-12-09 |
Abbvie Inc. |
Isolation and purification of antibodies using protein a affinity chromatography
|
|
CA2739077A1
(en)
*
|
2008-10-20 |
2010-04-29 |
Robert K. Hickman |
Antibodies that bind to il-18 and methods of purifying the same
|
|
RU2481824C2
(ru)
|
2008-10-29 |
2013-05-20 |
Аблинкс Н.В |
Препараты однодоменных антигенсвязывающих молекул
|
|
CN105646643A
(zh)
|
2008-10-29 |
2016-06-08 |
阿布林克斯公司 |
单域抗原结合性分子的纯化方法
|
|
US8168165B2
(en)
|
2008-12-23 |
2012-05-01 |
Abbott Laboratories |
Alkylated interleukin-18 compositions
|
|
US8349325B2
(en)
|
2008-12-23 |
2013-01-08 |
Abbott Laboratories |
Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making
|
|
MX2012002651A
(es)
|
2009-09-01 |
2012-05-22 |
Abbott Lab |
Inmunoglobulinas de dominio variable doble y usos de las mismas.
|
|
AR078651A1
(es)
|
2009-10-15 |
2011-11-23 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
PH12012501070A1
(en)
|
2009-12-08 |
2017-08-23 |
Abbott Gmbh & Co Kg |
Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration
|
|
CN102834413A
(zh)
*
|
2010-02-09 |
2012-12-19 |
葛兰素集团有限公司 |
代谢障碍的治疗
|
|
US20110229921A1
(en)
|
2010-03-18 |
2011-09-22 |
Abbott Laboratories |
METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS
|
|
KR20130100118A
(ko)
|
2010-08-03 |
2013-09-09 |
아비에 인코포레이티드 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
|
US9046513B2
(en)
|
2010-08-26 |
2015-06-02 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
CN102443063B
(zh)
*
|
2010-09-30 |
2013-10-23 |
成都康弘生物科技有限公司 |
抗TNFα的人源化Fab和人源化抗体及其用途
|
|
US20120115244A1
(en)
|
2010-11-09 |
2012-05-10 |
Abbott Laboratories |
Materials and methods for immunoassay of pterins
|
|
BR112013015508B1
(pt)
*
|
2010-12-20 |
2022-04-05 |
Medimmune Limited |
Molécula de anticorpo para il-18 humana, domínio vh isolado e domínio vl isolado, composição, uso de uma molécula de anticorpo ou do domínio vh isolado e do domínio vl isolado, molécula de ácido nucleico isolada, célula hospedeira procariótica recombinante, método para produzir um anticorpo, e método in vitro para medir il-18 em uma amostra de um indivíduo
|
|
WO2012088247A2
(en)
*
|
2010-12-22 |
2012-06-28 |
Medimmune, Llc |
Anti-c5/c5a/c5adesr antibodies and fragments
|
|
WO2012096264A1
(ja)
|
2011-01-11 |
2012-07-19 |
Jsr株式会社 |
感放射線性樹脂組成物及び感放射線性酸発生剤
|
|
WO2012149197A2
(en)
|
2011-04-27 |
2012-11-01 |
Abbott Laboratories |
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
|
|
CN104136462B
(zh)
|
2011-12-14 |
2017-06-09 |
艾伯维德国有限责任两合公司 |
用于诊断和治疗铁相关病症的组合物和方法
|
|
MX357708B
(es)
|
2011-12-14 |
2018-07-20 |
Abbvie Deutschland |
Composicion y metodo para el diagnostico y tratamiento de trastornos relacionados con hierro.
|
|
AR089529A1
(es)
|
2011-12-30 |
2014-08-27 |
Abbvie Inc |
Proteinas de union especificas duales dirigidas contra il-13 y/o il-17
|
|
US8993248B2
(en)
|
2011-12-31 |
2015-03-31 |
Abbott Laboratories |
Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use
|
|
AU2013211939C1
(en)
|
2012-01-27 |
2018-06-07 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for diagnosis and treatment of diseases associated with neurite degeneration
|
|
US9150645B2
(en)
|
2012-04-20 |
2015-10-06 |
Abbvie, Inc. |
Cell culture methods to reduce acidic species
|
|
US9181572B2
(en)
|
2012-04-20 |
2015-11-10 |
Abbvie, Inc. |
Methods to modulate lysine variant distribution
|
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
|
US9249182B2
(en)
|
2012-05-24 |
2016-02-02 |
Abbvie, Inc. |
Purification of antibodies using hydrophobic interaction chromatography
|
|
HK1211981A1
(en)
|
2012-09-02 |
2016-06-03 |
Abbvie Inc. |
Methods to control protein heterogeneity
|
|
US9512214B2
(en)
|
2012-09-02 |
2016-12-06 |
Abbvie, Inc. |
Methods to control protein heterogeneity
|
|
US9376489B2
(en)
|
2012-09-07 |
2016-06-28 |
Novartis Ag |
IL-18 binding molecules
|
|
PE20151179A1
(es)
|
2012-11-01 |
2015-09-12 |
Abbvie Inc |
Inmunoglobulinas de dominio variable dual anti-vegf/dll4 y usos de las mismas
|
|
WO2014080866A1
(ja)
*
|
2012-11-21 |
2014-05-30 |
一般財団法人化学及血清療法研究所 |
新規なヒト抗ｉｌ－１８抗体
|
|
DE112013006579B4
(de)
|
2013-02-02 |
2024-09-05 |
Duke University |
Verfahren zum Isolieren zirkulierender Tumorzellen
|
|
SG11201507230PA
(en)
|
2013-03-12 |
2015-10-29 |
Abbvie Inc |
Human antibodies that bind human tnf-alpha and methods of preparing the same
|
|
US9017687B1
(en)
|
2013-10-18 |
2015-04-28 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same using displacement chromatography
|
|
WO2014151878A2
(en)
|
2013-03-14 |
2014-09-25 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
|
|
WO2014159579A1
(en)
|
2013-03-14 |
2014-10-02 |
Abbvie Inc. |
MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
|
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
|
AU2014227732A1
(en)
|
2013-03-15 |
2015-09-17 |
Abbvie Inc. |
Dual specific binding proteins directed against IL-1 beta and IL-17
|
|
EP3003372B1
(en)
|
2013-06-07 |
2019-10-09 |
Duke University |
Inhibitors of complement factor h
|
|
WO2015031626A1
(en)
|
2013-08-28 |
2015-03-05 |
Abbvie Inc. |
Soluble cmet assay
|
|
WO2015032932A1
(en)
|
2013-09-05 |
2015-03-12 |
Ab2 Bio Sa |
Il-18 binding protein (il-18bp) in inflammatory diseases
|
|
US20160271230A1
(en)
|
2013-09-17 |
2016-09-22 |
University Health Network (Uhn): Technology Development And Commercialization |
Agents directed against a cis rgma/neogenin interaction or lipid rafts and use of the same in methods of treatment
|
|
US9598667B2
(en)
|
2013-10-04 |
2017-03-21 |
Abbvie Inc. |
Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
|
|
US9085618B2
(en)
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|
|
US8946395B1
(en)
|
2013-10-18 |
2015-02-03 |
Abbvie Inc. |
Purification of proteins using hydrophobic interaction chromatography
|
|
US9181337B2
(en)
|
2013-10-18 |
2015-11-10 |
Abbvie, Inc. |
Modulated lysine variant species compositions and methods for producing and using the same
|
|
US20150139988A1
(en)
|
2013-11-15 |
2015-05-21 |
Abbvie, Inc. |
Glycoengineered binding protein compositions
|
|
WO2016044736A1
(en)
*
|
2014-09-18 |
2016-03-24 |
Cell Signaling Technology, Inc. |
Altered antibodies and methods of making the same
|
|
WO2016061632A1
(en)
*
|
2014-10-23 |
2016-04-28 |
La Trobe University |
Fn14-binding proteins and uses thereof
|
|
US10093733B2
(en)
|
2014-12-11 |
2018-10-09 |
Abbvie Inc. |
LRP-8 binding dual variable domain immunoglobulin proteins
|
|
CN107660150B
(zh)
|
2015-03-05 |
2023-10-24 |
Ab2生物股份有限公司 |
Il-18结合蛋白(il-18bp)和抗体在炎性疾病中
|
|
CA3172682A1
(en)
|
2015-04-23 |
2016-10-27 |
Nantomics, Llc |
Cancer neoepitopes
|
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗ｖｅｇｆ、ｐｄｇｆ及／或其受體之結合蛋白
|
|
CA2998183A1
(en)
|
2015-09-11 |
2017-03-16 |
AbbVie Deutschland GmbH & Co. KG |
Methods for treating relapsing forms of multiple sclerosis
|
|
WO2017087784A1
(en)
|
2015-11-18 |
2017-05-26 |
Duke University |
Tumor infiltrating lymphocytes for treatment of cancer
|
|
JP6979976B2
(ja)
|
2016-03-10 |
2021-12-15 |
ヴィエラ バイオ，インコーポレーテッド |
Ｉｌｔ７結合分子及びその使用方法
|
|
TW202523689A
(zh)
|
2016-06-01 |
2025-06-16 |
美商艾伯維有限公司 |
治療脊髓損傷及疼痛之方法
|
|
US20170363620A1
(en)
|
2016-06-17 |
2017-12-21 |
Abbott Laboratories |
BIOMARKERS TO PREDICT NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)
|
|
EP3279667A1
(en)
|
2016-08-02 |
2018-02-07 |
Abbott Laboratories |
Cardiac troponin i and copeptin as biomarkers for short-term mortality in acute exacerbation of chronic obstructive pulmonary disease (aecopd)
|
|
CA3036714A1
(en)
|
2016-10-03 |
2018-04-12 |
Abbott Laboratories |
Improved methods of assessing uch-l1 status in patient samples
|
|
US10324041B2
(en)
|
2016-12-21 |
2019-06-18 |
Abbott Japan Co., Ltd. |
Optical imaging system using lateral illumination for digital assays
|
|
US11047854B2
(en)
|
2017-02-06 |
2021-06-29 |
Abbott Japan Llc |
Methods for reducing noise in signal-generating digital assays
|
|
US10416164B2
(en)
|
2017-02-08 |
2019-09-17 |
Silbiotech, Inc. |
Methods for determining breast cancer risk
|
|
EP3592384B1
(en)
|
2017-03-09 |
2025-07-02 |
MAB Discovery GmbH |
Antibodies specifically binding to human il-1r7
|
|
JP7346300B2
(ja)
|
2017-03-23 |
2023-09-19 |
アボット・ラボラトリーズ |
早期バイオマーカーであるユビキチンカルボキシ末端ヒドロラーゼｌ１を使用する、ヒト対象における外傷性脳損傷の程度の診断及び決定の一助となるための方法
|
|
EP3610268B1
(en)
|
2017-04-15 |
2025-09-24 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
|
|
JP7080899B2
(ja)
|
2017-04-28 |
2022-06-06 |
アボット・ラボラトリーズ |
同じヒト対象に由来する少なくとも２つの試料に対して早期バイオマーカーを使用する、外傷性脳損傷の超急性の診断及び決定の一助となるための方法
|
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
|
US10866251B2
(en)
|
2017-05-25 |
2020-12-15 |
Abbott Laboratories |
Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
|
|
WO2018222783A1
(en)
|
2017-05-30 |
2018-12-06 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin i and early biomarkers
|
|
EP3649474A1
(en)
|
2017-07-03 |
2020-05-13 |
Abbott Laboratories |
Improved methods for measuring ubiquitin carboxy-terminal hydrolase l1 levels in blood
|
|
US11426389B2
(en)
|
2017-07-28 |
2022-08-30 |
Duke University |
Compositions and methods for promoting hematopoietic stem cell regeneration
|
|
WO2019113525A2
(en)
|
2017-12-09 |
2019-06-13 |
Abbott Laboratories |
Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (tbi), using glial fibrillary acidic protein (gfap) and/or ubiquitin carboxy-terminal hydrolase l1 (uch-l1)
|
|
WO2019112860A1
(en)
|
2017-12-09 |
2019-06-13 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of gfap and uch-l1
|
|
WO2019133717A1
(en)
|
2017-12-29 |
2019-07-04 |
Abbott Laboratories |
Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury
|
|
JPWO2019194217A1
(ja)
*
|
2018-04-04 |
2021-04-15 |
株式会社ｍＡｂＰｒｏｔｅｉｎ |
検出感度の高いインターロイキン−１８タンパク質に対する抗体及びその応用
|
|
GB201809699D0
(en)
*
|
2018-06-13 |
2018-08-01 |
Singapore Health Serv Pte Ltd |
IL-11 antibodies
|
|
US12269874B2
(en)
|
2018-12-03 |
2025-04-08 |
mAbProtein Co., Ltd. |
Antibody that recognizes neoepitope of activated interleukin-18 proteins and application thereof
|
|
CN113453693A
(zh)
|
2018-12-20 |
2021-09-28 |
芝加哥大学 |
与rna修饰的位点特异性鉴定相关的组合物和方法
|
|
WO2020180695A1
(en)
|
2019-03-01 |
2020-09-10 |
Abbott Laboratories |
Methods for predicting major adverse cardiovascular events in subjects with coronary artery disease
|
|
KR102265432B1
(ko)
*
|
2019-08-20 |
2021-06-15 |
주식회사 케어젠 |
피부 미백 활성을 갖는 펩타이드 및 이의 용도
|
|
WO2021203013A2
(en)
|
2020-04-03 |
2021-10-07 |
Viela Bio, Inc. |
Methods of treating immune mediated pulmonary injury
|
|
CA3175523A1
(en)
|
2020-04-13 |
2021-10-21 |
Antti Virtanen |
Methods, complexes and kits for detecting or determining an amount of a .beta.-coronavirus antibody in a sample
|
|
ES3075793T3
(en)
|
2020-05-13 |
2026-08-07 |
Disc Medicine Inc |
Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis
|
|
AU2021273014A1
(en)
|
2020-05-13 |
2022-11-17 |
AbbVie Deutschland GmbH & Co. KG |
Anti-hemojuvelin (HJV) antibodies for treating anemia of chronic disease
|
|
US20220043000A1
(en)
|
2020-08-04 |
2022-02-10 |
Abbott Laboratories |
Methods and kits for detecting sars-cov-2 protein in a sample
|
|
WO2022029494A1
(en)
|
2020-08-04 |
2022-02-10 |
Abbott Rapid Diagnostics International Unlimited Company |
Assays for detecting sars-cov-2
|
|
CN112625129B
(zh)
*
|
2020-11-26 |
2022-05-20 |
江苏荃信生物医药股份有限公司 |
一种抗人白介素23及包含其的试剂盒及其检测方法
|
|
WO2022119841A1
(en)
|
2020-12-01 |
2022-06-09 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
|
WO2022147178A1
(en)
|
2020-12-30 |
2022-07-07 |
Abbott Laboratories |
Improved methods, reagents and kits for detergent-based inactivation of betacoronavirus prior to and/or while assessing a biological sample for sars-cov-2 antigen or antibody
|
|
WO2022147147A1
(en)
|
2020-12-30 |
2022-07-07 |
Abbott Laboratories |
Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
|
|
US20240158511A1
(en)
*
|
2021-03-26 |
2024-05-16 |
The General Hospital Corporation |
Humanized mAb107
|
|
EP4067375A1
(en)
*
|
2021-03-30 |
2022-10-05 |
Universität Ulm |
Fibril peptides
|
|
AU2022279156A1
(en)
|
2021-05-18 |
2023-11-02 |
Abbott Laboratories |
Methods of evaluating brain injury in a pediatric subject
|
|
WO2022266034A1
(en)
|
2021-06-14 |
2022-12-22 |
Abbott Laboratories |
Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
|
|
JP7880582B2
(ja)
|
2021-07-13 |
2026-06-26 |
国立大学法人東海国立大学機構 |
炎症性腸疾患を治療するための医薬組成物
|
|
WO2023028186A1
(en)
|
2021-08-27 |
2023-03-02 |
Abbott Laboratories |
Methods for detecting immunoglobulin g, subclass 4 (igg4) in a biological sample
|
|
CA3230038A1
(en)
|
2021-08-31 |
2023-03-09 |
Hongwei Zhang |
Methods and systems of diagnosing brain injury
|
|
CN118715440A
(zh)
|
2021-08-31 |
2024-09-27 |
雅培实验室 |
诊断脑损伤的方法和系统
|
|
WO2023056268A1
(en)
|
2021-09-30 |
2023-04-06 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
|
JP2025503439A
(ja)
|
2021-12-17 |
2025-02-04 |
アボット・ラボラトリーズ |
血液試料におけるｕｃｈ－ｌ１、ｇｆａｐ及び他のバイオマーカーを決定するためのシステム及び方法
|
|
JP2025507303A
(ja)
|
2022-02-04 |
2025-03-18 |
アボット・ラボラトリーズ |
試料におけるユビキチンカルボキシ末端ヒドロラーゼｌ１及び／又はグリア原線維性酸性タンパク質の存在を検出する又はその量を測定するためのラテラルフロー方法、アッセイ及びデバイス
|
|
WO2023161853A1
(en)
*
|
2022-02-23 |
2023-08-31 |
Bright Peak Therapeutics Ag |
Activatable il-18 polypeptides
|
|
WO2024006876A1
(en)
|
2022-06-29 |
2024-01-04 |
Abbott Laboratories |
Magnetic point-of-care systems and assays for determining gfap in biological samples
|
|
AU2023342055A1
(en)
|
2022-09-15 |
2025-03-13 |
Abbott Laboratories |
Biomarkers and methods for differentiating between mild and supermild traumatic brain injury
|
|
US20260235621A1
(en)
|
2022-11-10 |
2026-08-13 |
Abbott Laboratoris |
Methods of identifying macrotroponin in biological samples
|
|
JP2026517628A
(ja)
|
2023-04-04 |
2026-06-02 |
アボット・ラボラトリーズ |
対象が亜急性後天性脳損傷（ａｂｉ）を負った、負った可能性がある、又は負っていると推測されるかどうかを決定するためのバイオマーカーの使用
|
|
WO2024226971A1
(en)
|
2023-04-28 |
2024-10-31 |
Abbott Point Of Care Inc. |
Improved assays, cartridges, and kits for detection of biomarkers, including brain injury biomarkers
|
|
AU2024262099A1
(en)
|
2023-04-28 |
2025-12-11 |
Abbott Laboratories |
Diagnosis of late-stage hepatocellular carcinoma
|
|
WO2024243819A1
(zh)
*
|
2023-05-30 |
2024-12-05 |
上海洛启生物医药技术有限公司 |
抗白介素18受体的纳米抗体及其应用
|
|
CN120518762B
(zh)
*
|
2023-06-05 |
2025-12-26 |
北京东方百泰生物科技股份有限公司 |
一种结合il-11的抗体、其抗原结合片段及应用
|
|
JP2026525821A
(ja)
|
2023-06-20 |
2026-08-04 |
アポロ・エイピー４３・リミテッド |
アトピー性皮膚炎を処置するための抗ｉｌ－１８抗体療法
|
|
EP4791438A1
(en)
*
|
2023-10-13 |
2026-08-19 |
The Regents of The University of Michigan |
Carriers for drug conjugates
|
|
WO2025111148A1
(en)
|
2023-11-21 |
2025-05-30 |
Abbott Laboratories |
Sample analysis device and methods
|
|
KR20260115973A
(ko)
|
2023-11-21 |
2026-07-27 |
애벗트 라보라토리이즈 |
2차원 매트릭스 액적 어레이
|
|
AU2024411047A1
(en)
|
2023-12-28 |
2026-06-18 |
Abbott Laboratories |
Methods, systems, compounds, and kits for determining an analyte of interest in a test sample
|
|
WO2025193825A1
(en)
|
2024-03-13 |
2025-09-18 |
Abbott Laboratories |
Diagnosis and monitoring of liver disease
|
|
WO2025191541A1
(en)
|
2024-03-15 |
2025-09-18 |
Tocris Cookson Limited |
Horseradish peroxidase copolymers, conjugates, and uses thereof
|
|
WO2025198859A1
(en)
|
2024-03-21 |
2025-09-25 |
Abbott Laboratories |
Synthesis of thyroid hormone derivatives and their role as calibrators for thyroid hormone immunoassays
|
|
WO2025230857A1
(en)
|
2024-05-01 |
2025-11-06 |
Abbott Laboratories |
Improved methods for determining cardiac myosin binding protein c in biological samples
|
|
WO2025229563A1
(en)
*
|
2024-05-03 |
2025-11-06 |
Glaxosmithkline Intellectual Property Development Limited |
Methods of treating inflammatory bowel disease
|
|
WO2026112563A1
(en)
|
2024-11-25 |
2026-05-28 |
Abbott Laboratories |
Systems and methods for tbi adjudication
|